ATE508115T1 - CRYSTALLINE FORMS OF 4-Ä2-(4-METHYLPHENYLSULFANYL)PHENYLUPIPERIDINE WITH COMBINED SEROTONIN AND NOREPINEPHRINE REUPPOST INHIBITION FOR THE TREATMENT OF NEUROPATHIC PAIN - Google Patents

CRYSTALLINE FORMS OF 4-Ä2-(4-METHYLPHENYLSULFANYL)PHENYLUPIPERIDINE WITH COMBINED SEROTONIN AND NOREPINEPHRINE REUPPOST INHIBITION FOR THE TREATMENT OF NEUROPATHIC PAIN

Info

Publication number
ATE508115T1
ATE508115T1 AT07764496T AT07764496T ATE508115T1 AT E508115 T1 ATE508115 T1 AT E508115T1 AT 07764496 T AT07764496 T AT 07764496T AT 07764496 T AT07764496 T AT 07764496T AT E508115 T1 ATE508115 T1 AT E508115T1
Authority
AT
Austria
Prior art keywords
reuppost
phenylupiperidine
methylphenylsulfanyl
norepinephrine
inhibition
Prior art date
Application number
AT07764496T
Other languages
German (de)
Inventor
Benny Bang-Andersen
Andre Faldt
Tine Stensbyl
Silke Miller
De Diego Heidi Lopez
Original Assignee
Lundbeck & Co As H
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lundbeck & Co As H filed Critical Lundbeck & Co As H
Priority claimed from PCT/DK2007/050076 external-priority patent/WO2007144006A1/en
Application granted granted Critical
Publication of ATE508115T1 publication Critical patent/ATE508115T1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/20—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4465—Non condensed piperidines, e.g. piperocaine only substituted in position 4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/451—Non condensed piperidines, e.g. piperocaine having a carbocyclic group directly attached to the heterocyclic ring, e.g. glutethimide, meperidine, loperamide, phencyclidine, piminodine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C229/04—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C229/24—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having more than one carboxyl group bound to the carbon skeleton, e.g. aspartic acid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C55/00—Saturated compounds having more than one carboxyl group bound to acyclic carbon atoms
    • C07C55/02—Dicarboxylic acids
    • C07C55/08—Malonic acid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C55/00—Saturated compounds having more than one carboxyl group bound to acyclic carbon atoms
    • C07C55/02—Dicarboxylic acids
    • C07C55/12—Glutaric acid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/01—Saturated compounds having only one carboxyl group and containing hydroxy or O-metal groups
    • C07C59/08—Lactic acid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13—Crystalline forms, e.g. polymorphs

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
AT07764496T 2006-06-16 2007-06-15 CRYSTALLINE FORMS OF 4-Ä2-(4-METHYLPHENYLSULFANYL)PHENYLUPIPERIDINE WITH COMBINED SEROTONIN AND NOREPINEPHRINE REUPPOST INHIBITION FOR THE TREATMENT OF NEUROPATHIC PAIN ATE508115T1 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US80500906P 2006-06-16 2006-06-16
DKPA200600816 2006-06-16
DKPA200700423 2007-03-20
PCT/DK2007/050076 WO2007144006A1 (en) 2006-06-16 2007-06-15 Crystalline forms of 4- [2- (4-methylphenylsulfanyl) -phenyl] piperidine with combined serotonin and norepinephrine reuptake inhibition for the treatment of neuropathic pain

Publications (1)

Publication Number Publication Date
ATE508115T1 true ATE508115T1 (en) 2011-05-15

Family

ID=39722478

Family Applications (1)

Application Number Title Priority Date Filing Date
AT07764496T ATE508115T1 (en) 2006-06-16 2007-06-15 CRYSTALLINE FORMS OF 4-Ä2-(4-METHYLPHENYLSULFANYL)PHENYLUPIPERIDINE WITH COMBINED SEROTONIN AND NOREPINEPHRINE REUPPOST INHIBITION FOR THE TREATMENT OF NEUROPATHIC PAIN

Country Status (15)

Country Link
JP (1) JP2014098017A (en)
KR (1) KR101472595B1 (en)
AR (1) AR061480A1 (en)
AT (1) ATE508115T1 (en)
BR (1) BRPI0712758A2 (en)
CA (1) CA2784304A1 (en)
DE (1) DE602007014372D1 (en)
DK (1) DK2044020T3 (en)
MY (1) MY150698A (en)
NZ (1) NZ572856A (en)
PT (1) PT2044020E (en)
RS (1) RS51687B (en)
SI (1) SI2044020T1 (en)
TN (1) TNSN08461A1 (en)
TW (1) TWI444365B (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101972931B1 (en) 2017-10-19 2019-04-26 재단법인대구경북과학기술원 Balloon type ecog measuring device and its manufacturing method
CN116930385B (en) * 2023-08-08 2024-02-20 北京爱思益普生物科技股份有限公司 Method for measuring concentration of compound in high-salt-concentration preparation

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA81749C2 (en) * 2001-10-04 2008-02-11 Х. Луннбек А/С Derivated of phenylpiperazine as serotonin reuptake inhibitorS
PL2044020T3 (en) * 2006-06-16 2011-09-30 H Lundbeck As Crystalline forms of 4- [2- (4-methylphenylsulfanyl) -phenyl]piperidine with combined serotonin and norepinephrine reuptake inhibition for the treatment of neuropathic pain

Also Published As

Publication number Publication date
DK2044020T3 (en) 2011-08-15
DE602007014372D1 (en) 2011-06-16
TNSN08461A1 (en) 2010-04-14
AR061480A1 (en) 2008-08-27
JP2014098017A (en) 2014-05-29
KR20090018630A (en) 2009-02-20
TWI444365B (en) 2014-07-11
MY150698A (en) 2014-02-28
CA2784304A1 (en) 2007-12-21
NZ572856A (en) 2012-02-24
PT2044020E (en) 2011-05-12
SI2044020T1 (en) 2011-06-30
RS51687B (en) 2011-10-31
TW200817329A (en) 2008-04-16
KR101472595B1 (en) 2014-12-15
BRPI0712758A2 (en) 2012-09-25

Similar Documents

Publication Publication Date Title
ATE429218T1 (en) PINOLENEIC ACID FOR THE TREATMENT OF OBESITY
ATE434620T1 (en) DIHYDROTHIENOPYRIMIDINES FOR THE TREATMENT OF INFLAMMATORY DISEASES
DE502005010499D1 (en) Implant for the treatment of obesity
ATE534633T1 (en) INDAZOL DERIVATIVES FOR THE TREATMENT OF HSP90-INDUCED DISEASES
ATE438623T1 (en) AROYL-O-PIPERIDINE DERIVATIVES FOR THE TREATMENT OF PROBLEMS RELATED TO DIABETES
ATE490825T1 (en) TREATMENT OF MINERAL SLUDGES WITH IMPROVED PLANT GROWTH REHABILITATION
ATE550338T1 (en) SPIROPIPERIDINE INHIBITORS OF BETA-SECRETASE FOR THE TREATMENT OF ALZHEIMER'S DISEASE
ATE550329T1 (en) HETEROBICYCLIC SULFONAMIDE DERIVATIVES FOR THE TREATMENT OF DIABETES
ATE527241T1 (en) PYRIDIAZINONE DERIVATIVES FOR THE TREATMENT OF TUMORS
ATE512948T1 (en) BIPHENYL-SULFONYL AND PHENYL-HETEROARYL-SULFONYL MODULATORS OF THE HISTAMINE H3 RECEPTOR FOR THE TREATMENT OF RELATED DISEASES
ATE545418T1 (en) COMPOSITIONS AND KITS FOR THE TREATMENT OF INFLUENZA
IL201309A0 (en) Novel n - (8 - heteroaryltetrahydronaphtalene - 2yl) or n - (5 - heteroarylchromane - 3 - yl) carboxamide derivatives for the treatment of pain
ATE493986T1 (en) DIARYLUREAS FOR THE TREATMENT OF PULMONARY HYPERTENSION
ATE447551T1 (en) BIPHENYLOXYACETIC ACID - DERIVATIVES FOR THE TREATMENT OF RESPIRATORY DISEASES
ATE532507T1 (en) NERAMEXANE FOR THE TREATMENT OF SUBACUTE TINNITUS
DE602006009899D1 (en) USE OF OXYCODONE FOR THE TREATMENT OF VISCERAL PAIN
DE602006013945D1 (en) SUBSTITUTED CYCLOPENTANE OR CYCLOPENTANONE FOR THE TREATMENT OF EYE HIGH PRESSURE
DE502006007982D1 (en) NEW MEDICINE COMBINATIONS FOR THE TREATMENT OF RESPIRATORY DISEASES
ATE509621T1 (en) USE OF 2,5-DIHYDROXYBENZENE DERIVATIVES TO TREAT ARTHRITIS AND PAIN
DE602005016141D1 (en) S-MIRTAZAPINE FOR THE TREATMENT OF HITZEWALLUNGEN
ATE504297T1 (en) VISNADIN FOR THE TREATMENT OF ITCH OF THE SCALP
ATE537178T1 (en) NEW CLASS OF SPIRO-PIPERIDINES FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES
DE112007001255A5 (en) Terguride / proterguride for the treatment of chronic pain
IL213703A0 (en) Compounds and methods for the treatment of pain and other diseases
ATE532787T1 (en) POLYCYCLIC AGENTS FOR THE TREATMENT OF RESPIRATORY SYNCYTIAL VIRUS INFECTIONS

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 2044020

Country of ref document: EP